NCT05896644

Brief Summary

The goal of this clinical trial is to assess the impact of participation in Eat Well for diabetes patients who are at risk of food insecurity. The main questions it aims to answer are:

  • whether there is a difference in Haemoglobin (Hb) A1c measurements and emergency department (ED) utilization between the Eat Well and control groups up to 18 months post-program completion.
  • whether there are differences in cardiometabolic health-related outcomes for Eat Well participants. Participants in the program will receive gift/debit cards for fruits and vegetables and educational nutrition materials. Researchers will compare Eat Well participants with those only receiving educational materials to see if there are differences in cardiometabolic health outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,177

participants targeted

Target at P75+ for not_applicable diabetes-mellitus

Timeline
Completed

Started Jun 2023

Typical duration for not_applicable diabetes-mellitus

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 26, 2023

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 9, 2023

Completed
11 days until next milestone

Study Start

First participant enrolled

June 20, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 16, 2024

Completed
1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

May 8, 2026

Status Verified

May 1, 2026

Enrollment Period

1.1 years

First QC Date

May 26, 2023

Last Update Submit

May 6, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in HbA1C

    A measure of average blood sugar levels over the past 3 months.

    18 months pre program, during program enrollment, up to 12 months

  • Change in number of ED Visits

    Number of ED visits throughout the study period

    up to 18 months pre program, during program enrollment, up to 12 months

Secondary Outcomes (10)

  • Outpatient visits

    up to 18 months pre program, during program, and up to 18 months post program

  • Hospitalizations

    up to 18 months pre program, during program, and up to 18 months post program

  • Change in weight

    up to 18 months pre program, during program, and up to 18 months post program enrollment

  • Change in body mass index (BMI)

    up to 18 months pre program, during program, and up to 18 months post program

  • Change in cholesterol

    up to 18 months pre program, during program, and up to 18 months post program

  • +5 more secondary outcomes

Study Arms (2)

Eat Well

EXPERIMENTAL

The experimental group will participate in the Eat Well Produce Prescription program, receiving an $80 monthly benefit for eligible produce for 12 months and diabetes education materials through email, including curated nutrition and diet information from the Diabetes Resource Page, consistent with standard of care at Duke University Health System.

Other: Eat Well

Control

NO INTERVENTION

The control group will receive usual care (including diabetes educational materials) without the prescription benefit.

Interventions

A program offered by Reinvestment Partners giving clients gift/debit cards that allow the purchase of WIC approved fruits and vegetables.

Eat Well

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Be active in the Duke Diabetes Registry in the past 12 months AND
  • have had at least one outpatient A1c measurement AND
  • are at risk for food insecurity as defined by one of the following:
  • answered often true or sometimes true on one or both of the food insecurity questions as part of the electronic health record social history section (Maestro Care/ Epic of Verona WI) OR
  • answered hard or very hard to the financial stress question as part of the electronic health record social history section (Maestro Care/ Epic of Verona WI) OR
  • has Medicaid as insurance payer OR
  • lives in Area Deprivation Index (ADI) zip code of 7th decile or harder

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke University Health System

Durham, North Carolina, 27708, United States

Location

Related Publications (3)

  • Rader A, Buckman C, Pignone M, German JC, Spratt SE, McPeek Hinz E, Brucker A, Hoeffler S, Kane RM, Drake C. Factors Associated with Produce Prescription Program Enrollment and Benefit Use Among Patients with Diabetes and At Risk for Food Insecurity. J Nutr. 2026 Apr 24:101548. doi: 10.1016/j.tjnut.2026.101548. Online ahead of print.

  • Drake C, Buckman C, Brucker A, McPeek Hinz E, Pignone M, Shaikha H, Rader A, Granados I, Goldstein BA, Chamorro C, Hoeffler S, Wirth C, Spratt SE. Produce Prescription Subsidy for Patients With Diabetes: A Pragmatic Randomized Clinical Trial. JAMA Intern Med. 2026 Apr 1;186(4):416-424. doi: 10.1001/jamainternmed.2025.8008.

  • Drake C, Granados I, Rader A, Brucker A, Hoeffler S, Goldstein BA, Chamorro C, Johnson F, Hinz EM, Bedoya AD, German JC, Hauser J, Thacker C, Spratt SE. Addressing cost barriers to healthy eating with Eat Well, a prescription produce subsidy, for patients with diabetes and at risk for food insecurity: Study protocol for a type 1 hybrid effectiveness-implementation pragmatic randomized controlled trial. Contemp Clin Trials. 2024 Oct;145:107655. doi: 10.1016/j.cct.2024.107655. Epub 2024 Aug 5.

Related Links

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 26, 2023

First Posted

June 9, 2023

Study Start

June 20, 2023

Primary Completion

July 16, 2024

Study Completion

May 1, 2026

Last Updated

May 8, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Access to all participant data and information will be restricted to authorized personnel. Internal monitoring of data may occur as required by Duke for investigator-initiated clinical research.

Locations